trending Market Intelligence /marketintelligence/en/news-insights/trending/umyfokfy3wjgyrq7kh9ddw2 content esgSubNav
In This List

American Renal Associates launches common share offering by stockholders

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


American Renal Associates launches common share offering by stockholders

American Renal Associates Holdings Inc. announced the launch of an underwritten public offering of 5 million common shares by certain stockholders including Centerbridge Capital Partners LP and certain of its affiliates.

The stockholders are expected to grant to the underwriters an option to buy up to an additional 750,000 shares.

The Beverly, Mass.-based dialysis services provider is not offering any stock in this offering and will not receive any proceeds from the sale of the shares by the selling stockholders.

Bank of America Merrill Lynch, J.P. Morgan and SunTrust Robinson Humphrey are acting as book-running managers and as representative of the underwriters for the offering. Barclays, Goldman Sachs & Co. LLC and Wells Fargo Securities are also acting as book-running managers for the offering.